
Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges
VJHemOnc Podcast
00:00
Emerging Gene Therapies for Hemophilia: Challenges and Innovations
This chapter delves into the latest developments in gene therapies for hemophilia A and B, emphasizing the variances in patient outcomes and the obstacles in achieving a permanent cure. It also reviews the evolution of therapeutic strategies since 2022, particularly the use of adeno-associated viral vectors and novel bioengineering techniques.
Transcript
Play full episode